Moreover, inhibition of autophagy in CRC cells thwarts their ability to use FAs and hinders their proliferation, suggesting that mutant KRAS controls lipid fate by modulating the autophagic machinery [4]. The gene discussed is KRAS; the disease is colorectal carcinoma.